|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Synthesis and biological activity of the penem antibiotic men 10700 and its orally absorbed ester men 11505 显示文摘 | Arcamone F M Auramura M Perrotta E | 2000 | J Antibiot2000，53，10： | 1 |
| 2 | N-on-covalent Complexes between DNA-binding Drugs and Double-stranded Deoxyoligonucleotides: A Study by Ionspray Mass Spectrometry显示文摘 | Triolo A Arcamone FM Raffaelli A | 1997 | J Mass Spectrom1997，32，11： | 1 |
| 3 | Non-covalent Complexes Between DNA-binding Drugs and Double-stranded Deoxyoligonucleotides:A Study by Ionspray Mass Spectrometry显示文摘 | Triolo A Arcamone FM Raffaelli A | 1997 | J Mass Spectrom1997，32，11： | 1 |
| 4 | Adriamycin 14-hydroxydaunomycin, a new antitumor antibiotic from Speucetius var caesius 显示文摘 | Arcamone F Cassinelli G Fantini G | 1969 | Biotechnol Bioeng1969，9，2： | 1 |
| 5 | Ghrelin in the gastroenteric tract of birds: immunoreactivity expression 显示文摘 | Neglia S Arcamone N Esposito V | 2004 | Veterinary Research Communications2004，28，： | 1 |
| 6 | Multiple Effects of Berberine Derivatives on Colon Cancer Cells显示文摘 | Luis Miguel Guamán Ortiz Micol Tillhon Michael Parks Ilaria Dutto Ennio Prosperi Monica Savio Andrea G. Arcamone Franco Buzzetti Paolo Lombardi Anna Ivana Scovassi Steve Winder | 2014 | BioMed Research International2014，，： | 1 |
| 7 | Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides 显示文摘 | Arcamone F Animati F Bigioni M | 1999 | Biochem Pharmacol1999，57，10： | 1 |
| 8 | Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplantineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | CORAZZLLI G CAPOBIANCO G ARCAMONE M etal | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
| 9 | Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone显示文摘 | Arcamone F Penco S Vigevani A | 1975 | LIMed Chem1975，18，7： | 1 |
| 10 | Synthesis and antitumor properties of new glycosides of daunomycinone and adriamyeinone 显示文摘 | Arcamone F Penco S Vigevani A | 1975 | JMed Chem1975，18，7： | 1 |
| 11 | MEMI0700,a new penem antibiotic:in vitro activity and its correlation with β-lactamase stability,PBP affinity and diffusion through the bacterial cell wall显示文摘 | FONTANA R ALTAMURA M ARCAMONE F | 1988 | J Antimicrob Chemother1988，41，5： | 1 |
| 12 | Synthesis and antitumor activity of 4-demethoxy-daunorubicin,4-demethoxy-7,9-diepidaunorubicin,and their B anomers显示文摘 | Arcamone F Bernardi L Giardino P | 1976 | Canc Chemoth Pharm1976，60，： | 1 |
| 13 | Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells 显示文摘 | Napoli S Negri U Arcamone F | 2006 | Nucleic Acids Res2006，34，2： | 1 |
| 14 | Synthesis and antitumour activity of new daunorubicin and adriamycin analogues显示文摘 | Arcamone F Bernardi L Patelli B | 1978 | Experientia1978，34，： | 1 |
| 15 | Long-term result of gemcit-abine plus oxaliplatin without rituximab as salvage treatment for transplantineligible patients with refractory/relapsing B-cell lymphoma显示文摘 | Corazzelli G Capobianco G Arcamone M | 2009 | Cancer Chemother Pharmacol2009，64，5： | 1 |
| 16 | Men10700,a new penem antibiotic:in-vitro activity and its correlation with beta-lactamase stability,PBP affinity and diffusion through the bacterial cell wall显示文摘 | FONTANA R ALTAMURA M ARCAMONE F | 1998 | J Antimicrob Chemother1998，41，5： | 1 |
| 17 | MEM10700,a new penem antibiotic:in vitro activity and its correlation withβ-lactamase stability,PBP affinity and diffusion through the bacterial cell wall显示文摘 | Fontana R Altamura M Arcamone F | 1988 | J Antimicrob Chemother1988，41，： | 1 |
| 18 | New developments in antitumor anthracyclines显示文摘 | ARCAMONE F ANIMATI F CAPRANICO G | 1997 | Pharmacol Ther1997，76，： | 1 |
| 19 | From the pigments of the actinomycetes to third generation antitumor anthracyclines显示文摘 | ARCAMONE F | 1998 | Biochimie1998，80，： | 1 |
| 20 | Long - term results of gemcitabine plus oxaliplatin with and without rit- uximab as salvage treatment for transplant - ineligible pa- tients with refractory/relapsing B - cell lymphoma 显示文摘 | Corazzlli G Capobianco G Arcamone M | 2009 | Cancer Chemother Pharmaco12009，64，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员